4595 Share Price | Mizuho Medy Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Mizuho Medy Co., Ltd. with Similar Stocks

CYBERDYNE, Inc.Shofu, Inc.FRANCE BED HOLDINGS CO., LTD.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Negative results in Jun 26

ROCE(HY) Lowest at 18.03%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.06 times
NET SALES(Q) Lowest at JPY 1,325 MM

With ROE of 17.72%, it has a very attractive valuation with a 1.74 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 31,777 Million (Small Cap)

P/E

10.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.68

Return on Equity

17.72%

Price to Book

1.73

Revenue and Profits:

Net Sales:

1,325 Million

(Quarterly Results - Jun 2026)

Net Profit:

221 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

19.42%

6 Months

14.17%

1 Year

-1.0%

2 Years

57.82%

3 Years

35.36%

4 Years

34.83%

5 Years

107.76%

Mizuho Medy Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

14.39%

EBIT Growth (5y)

27.01%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.65

Sales to Capital Employed (avg)

0.65

Tax Ratio

27.70%

Dividend Payout Ratio

55.62%

Pledged Shares

Institutional Holding

ROCE (avg)

121.97%

ROE (avg)

37.40%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.74

EV to EBIT

4.52

EV to EBITDA

4.25

EV to Capital Employed

3.34

EV to Sales

1.79

PEG Ratio

Dividend Yield

ROCE (Latest)

73.90%

ROE (Latest)

17.72%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -0.15% vs -31.10% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -9.05% vs -53.18% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,325.00",
          "val2": "1,327.00",
          "chgp": "-0.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "308.00",
          "val2": "419.00",
          "chgp": "-26.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "221.00",
          "val2": "243.00",
          "chgp": "-9.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "179.60%",
          "val2": "266.00%",
          "chgp": "-8.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -1.48% vs 4.00% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.22% vs -0.03% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,260.00",
          "val2": "11,429.00",
          "chgp": "-1.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,864.00",
          "val2": "5,104.00",
          "chgp": "-4.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,425.00",
          "val2": "3,773.00",
          "chgp": "-9.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "412.70%",
          "val2": "430.30%",
          "chgp": "-1.76%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]